Reports

Ideas That Generate Results

Aurobindo Pharma Limited - Company Analysis

Aurobindo Pharma Limited - Company Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2011| No. of Pages : 30

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 150.00
CD-ROM Mail Delivery
US$ 200.00
Hard Copy Mail Delivery
US$ 200.00
Electronic Access - Multi-User License
US$ 300.00

List of Figures:

Figure 2-1: Aurobindo Pharma Limited - Revenue by Geographical Distribution (Million US$), FY 2009 & FY 2010
Figure 3-1: Aurobindo Pharma Limited - Stock Chart

List of Tables:

Table 1-1: Aurobindo Pharma Limited - Ticker Codes at various Stock Exchanges
Table 1-2: Aurobindo Pharma Limited - Major Mergers & Acquisitions (2006 to 2009)
Table 1-3: Aurobindo Pharma Limited - Key Management People
Table 3-1: Aurobindo Pharma Limited - Financial Summary (Million US$), FY 2010
Table 3-2: Aurobindo Pharma Limited - Breakup of Revenue & Sales (Million US$), FY 2008 to FY 2010
Table 3-3: Aurobindo Pharma Limited - Key Financial Ratio (FY 2008 to FY 2010)
Table 3-4: Aurobindo Pharma Limited - Earning & Income Estimates (Million US$), FY 2008 to FY 2010
Table 5-1: Lupin Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-2: Lupin Limited - SWOT Analysis
Table 5-3: Cipla Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-4: Cipla Limited - SWOT Analysis
Table 5-5: Ranbaxy Laboratories Limited - Key Financials (Million US$), 2008-2010
Table 5-6: Ranbaxy Laboratories Limited - SWOT Analysis
Table 5-7: Cadila Healthcare Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-8: Cadila Healthcare Limited - SWOT Analysis

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.